This report contains market size and forecasts of Pharma Ophthalmic in global, including the following market information:
Global Pharma Ophthalmic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pharma Ophthalmic Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Pharma Ophthalmic companies in 2020 (%)
The global Pharma Ophthalmic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Ophthalmic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma Ophthalmic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, By Type, 2020 (%)
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
Global Pharma Ophthalmic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, By Application, 2020 (%)
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Global Pharma Ophthalmic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Ophthalmic revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pharma Ophthalmic revenues share in global market, 2020 (%)
Key companies Pharma Ophthalmic sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Pharma Ophthalmic sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pharma Ophthalmic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma Ophthalmic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma Ophthalmic Overall Market Size
2.1 Global Pharma Ophthalmic Market Size: 2021 VS 2027
2.2 Global Pharma Ophthalmic Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pharma Ophthalmic Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pharma Ophthalmic Players in Global Market
3.2 Top Global Pharma Ophthalmic Companies Ranked by Revenue
3.3 Global Pharma Ophthalmic Revenue by Companies
3.4 Global Pharma Ophthalmic Sales by Companies
3.5 Global Pharma Ophthalmic Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pharma Ophthalmic Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pharma Ophthalmic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharma Ophthalmic Players in Global Market
3.8.1 List of Global Tier 1 Pharma Ophthalmic Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharma Ophthalmic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharma Ophthalmic Market Size Markets, 2021 & 2027
4.1.2 Retinal disorders drugs
4.1.3 Allergic, inflammatory and infective drugs
4.1.4 Glaucoma drugs
4.1.5 Dry eye drugs
4.1.6 Other ophthalmic drugs
4.2 By Type - Global Pharma Ophthalmic Revenue & Forecasts
4.2.1 By Type - Global Pharma Ophthalmic Revenue, 2016-2021
4.2.2 By Type - Global Pharma Ophthalmic Revenue, 2022-2027
4.2.3 By Type - Global Pharma Ophthalmic Revenue Market Share, 2016-2027
4.3 By Type - Global Pharma Ophthalmic Sales & Forecasts
4.3.1 By Type - Global Pharma Ophthalmic Sales, 2016-2021
4.3.2 By Type - Global Pharma Ophthalmic Sales, 2022-2027
4.3.3 By Type - Global Pharma Ophthalmic Sales Market Share, 2016-2027
4.4 By Type - Global Pharma Ophthalmic Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharma Ophthalmic Market Size, 2021 & 2027
5.1.2 Glaucoma
5.1.3 Dry eye syndrome
5.1.4 Retinal diseases
5.1.5 Other ophthalmic indications
5.2 By Application - Global Pharma Ophthalmic Revenue & Forecasts
5.2.1 By Application - Global Pharma Ophthalmic Revenue, 2016-2021
5.2.2 By Application - Global Pharma Ophthalmic Revenue, 2022-2027
5.2.3 By Application - Global Pharma Ophthalmic Revenue Market Share, 2016-2027
5.3 By Application - Global Pharma Ophthalmic Sales & Forecasts
5.3.1 By Application - Global Pharma Ophthalmic Sales, 2016-2021
5.3.2 By Application - Global Pharma Ophthalmic Sales, 2022-2027
5.3.3 By Application - Global Pharma Ophthalmic Sales Market Share, 2016-2027
5.4 By Application - Global Pharma Ophthalmic Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pharma Ophthalmic Market Size, 2021 & 2027
6.2 By Region - Global Pharma Ophthalmic Revenue & Forecasts
6.2.1 By Region - Global Pharma Ophthalmic Revenue, 2016-2021
6.2.2 By Region - Global Pharma Ophthalmic Revenue, 2022-2027
6.2.3 By Region - Global Pharma Ophthalmic Revenue Market Share, 2016-2027
6.3 By Region - Global Pharma Ophthalmic Sales & Forecasts
6.3.1 By Region - Global Pharma Ophthalmic Sales, 2016-2021
6.3.2 By Region - Global Pharma Ophthalmic Sales, 2022-2027
6.3.3 By Region - Global Pharma Ophthalmic Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pharma Ophthalmic Revenue, 2016-2027
6.4.2 By Country - North America Pharma Ophthalmic Sales, 2016-2027
6.4.3 US Pharma Ophthalmic Market Size, 2016-2027
6.4.4 Canada Pharma Ophthalmic Market Size, 2016-2027
6.4.5 Mexico Pharma Ophthalmic Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pharma Ophthalmic Revenue, 2016-2027
6.5.2 By Country - Europe Pharma Ophthalmic Sales, 2016-2027
6.5.3 Germany Pharma Ophthalmic Market Size, 2016-2027
6.5.4 France Pharma Ophthalmic Market Size, 2016-2027
6.5.5 U.K. Pharma Ophthalmic Market Size, 2016-2027
6.5.6 Italy Pharma Ophthalmic Market Size, 2016-2027
6.5.7 Russia Pharma Ophthalmic Market Size, 2016-2027
6.5.8 Nordic Countries Pharma Ophthalmic Market Size, 2016-2027
6.5.9 Benelux Pharma Ophthalmic Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pharma Ophthalmic Revenue, 2016-2027
6.6.2 By Region - Asia Pharma Ophthalmic Sales, 2016-2027
6.6.3 China Pharma Ophthalmic Market Size, 2016-2027
6.6.4 Japan Pharma Ophthalmic Market Size, 2016-2027
6.6.5 South Korea Pharma Ophthalmic Market Size, 2016-2027
6.6.6 Southeast Asia Pharma Ophthalmic Market Size, 2016-2027
6.6.7 India Pharma Ophthalmic Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pharma Ophthalmic Revenue, 2016-2027
6.7.2 By Country - South America Pharma Ophthalmic Sales, 2016-2027
6.7.3 Brazil Pharma Ophthalmic Market Size, 2016-2027
6.7.4 Argentina Pharma Ophthalmic Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pharma Ophthalmic Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pharma Ophthalmic Sales, 2016-2027
6.8.3 Turkey Pharma Ophthalmic Market Size, 2016-2027
6.8.4 Israel Pharma Ophthalmic Market Size, 2016-2027
6.8.5 Saudi Arabia Pharma Ophthalmic Market Size, 2016-2027
6.8.6 UAE Pharma Ophthalmic Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Pharma Ophthalmic Major Product Offerings
7.1.4 Novartis Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Pharma Ophthalmic Major Product Offerings
7.2.4 Allergan Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.2.5 Allergan Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharma Ophthalmic Major Product Offerings
7.3.4 Roche Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.3.5 Roche Key News
7.4 Valeant
7.4.1 Valeant Corporate Summary
7.4.2 Valeant Business Overview
7.4.3 Valeant Pharma Ophthalmic Major Product Offerings
7.4.4 Valeant Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.4.5 Valeant Key News
7.5 Regeneron
7.5.1 Regeneron Corporate Summary
7.5.2 Regeneron Business Overview
7.5.3 Regeneron Pharma Ophthalmic Major Product Offerings
7.5.4 Regeneron Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.5.5 Regeneron Key News
7.6 Santen
7.6.1 Santen Corporate Summary
7.6.2 Santen Business Overview
7.6.3 Santen Pharma Ophthalmic Major Product Offerings
7.6.4 Santen Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.6.5 Santen Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Pharma Ophthalmic Major Product Offerings
7.4.4 Bayer Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.7.5 Bayer Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharma Ophthalmic Major Product Offerings
7.8.4 Pfizer Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 Senju
7.9.1 Senju Corporate Summary
7.9.2 Senju Business Overview
7.9.3 Senju Pharma Ophthalmic Major Product Offerings
7.9.4 Senju Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.9.5 Senju Key News
7.10 Akorn
7.10.1 Akorn Corporate Summary
7.10.2 Akorn Business Overview
7.10.3 Akorn Pharma Ophthalmic Major Product Offerings
7.10.4 Akorn Pharma Ophthalmic Sales and Revenue in Global (2016-2021)
7.10.5 Akorn Key News
8 Global Pharma Ophthalmic Production Capacity, Analysis
8.1 Global Pharma Ophthalmic Production Capacity, 2016-2027
8.2 Pharma Ophthalmic Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharma Ophthalmic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharma Ophthalmic Supply Chain Analysis
10.1 Pharma Ophthalmic Industry Value Chain
10.2 Pharma Ophthalmic Upstream Market
10.3 Pharma Ophthalmic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharma Ophthalmic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pharma Ophthalmic in Global Market
Table 2. Top Pharma Ophthalmic Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pharma Ophthalmic Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pharma Ophthalmic Revenue Share by Companies, 2016-2021
Table 5. Global Pharma Ophthalmic Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Pharma Ophthalmic Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pharma Ophthalmic Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Pharma Ophthalmic Product Type
Table 9. List of Global Tier 1 Pharma Ophthalmic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma Ophthalmic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn